Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00329485
Status:
TERMINATED
Last Update Posted:
2007-08-02
First Post:
2006-05-23
Brief Title:
The Effect of Ribose on B-Type Natriuretic Peptide BNP Levels in Congestive Heart Failure Patients
Sponsor:
Valen Labs
Organization:
Valen Labs
Study Overview
Official Title:
The Effect of Ribose on B-Type Natriuretic Peptide Levels in Congestive Heart Failure Patients
Status:
TERMINATED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Poor recruitment and through put
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to test the effectiveness of CORvalen a medical food to increase cellular energy sufficiently to change or modify BNP levels in congestive heart failure patients
Detailed Description:
B-type natriuretic peptide BNP is a blood test commonly used to track the progress of congestive heart failure CORvalen a medical food contains D-Ribose ribose a natural substance that has been shown to improve the amount of energy compounds at the cellular level Congestive heart failure has been associated with a reduced level of high-energy compounds One researcher has called them an energy starvation in congestive heart failure This study will try to assess if increasing the amount of these energy compounds is sufficient to improve BNP levels Approximately 120 symptomatic congestive heart failure patients will participate in this 3 month study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| WIRB Study No 1076926 | None | None | None |